Dr. Muhammad Umair Bakhsh, MD

Dr. Bakhsh practices at Sante' Foundation Medical Group in Fresno, California.

Dr. Bakhsh's NPI, 1619226420, was assigned on September 7, 2012. Dr. Bakhsh graduated from Rawalpindi Medical College in 2008. Dr. Bakhsh holds California license A134291.

Dr. Bakhsh's primary practice is Sante' Foundation Medical Group, at 1313 E Herndon Ave Suite 101b/202 207/209 Suite 101b, Fresno, CA 93720-3306. The practice phone is (559) 439-6808.

Dr. Bakhsh's primary practice is Sante' Foundation Medical Group in Fresno, California. Dr. Bakhsh is also affiliated with Community Regional Medical Center. The medical group on file is Santé Foundation Medical Group. Dmand AI also links Dr. Bakhsh to 2 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bakhsh practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bakhsh's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bakhsh is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bakhsh's licenses on file in 3 states: California, Connecticut and New York.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease, endocarditis and heart failure among the conditions Dr. Bakhsh treats.

CMS data shows 2,251 Medicare services from Dr. Bakhsh across 19 procedure codes in 2024, for 531 Medicare patients. Medicare paid $251,083 for them.

CMS counts 531 Medicare patients who saw Dr. Bakhsh in 2024. The largest group is 65 to 74, with 232 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bakhsh's median patient age at 66, with 54% women.

In 2024, Dr. Bakhsh wrote 967 Medicare Part D claims for 279 patients. 84% of them were for generic drugs. CMS names the drug for 805 of them, across 19 drugs with 11 or more claims each, at $135,619 in total drug cost. In 2023, CMS named 1,123 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Bakhsh for performance year 2024, reported as part of a group. Dr. Bakhsh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of coronary angioplasty and stenting by Dr. Bakhsh, more than 48% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Bakhsh in 2025. 2025 was the busiest year, with 2. Dr. Bakhsh's most frequent co-authors are Abhijay Jalota and Robert Sogomonian, MBA, MD.

CMS Open Payments shows 215 general payments to Dr. Bakhsh from 22 drug and device companies from 2016 to 2025. Grants make up the largest share, 47% of the total. Medtronic Vascular, Inc. paid the most, $21,323.

Dr. Bakhsh graduated from Rawalpindi Medical College in 2008.

Dr. Bakhsh is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.